Cathleen Matanle Net Worth

What's Cathleen Matanle's mailing address?

Cathleen's mailing address filed with the SEC is AMBAC FINANCIAL GROUP, INC., ONE STATE STREET PLAZA, NEW YORK, NY, 10004.

Insiders trading at AMBAC

Over the last 2001 years, insiders at AMBAC have traded over $0 worth of AMBAC stock and bought 620,503 units worth $8,494,882 . The most active insiders traders include Claude Le Blanc, Tavakoli Nader a C James Prieur. On average, AMBAC executives and independent directors trade stock every 3430 days with the average trade being worth of $117,111. The most recent stock trade was executed by R Sharon Smith on 8 August 2024, trading 1,100 units of AMBC stock currently worth $11,704.

What does AMBAC do?

ambac financial group, inc. (“ambac”), headquartered in new york city, is a holding company whose subsidiaries, including its principal operating subsidiary, ambac assurance corporation (“ambac assurance”), everspan financial guarantee corporation, and ambac assurance uk limited, provided financial guarantees and other financial services to clients in both the public and private sectors globally. ambac assurance, including the segregated account of ambac assurance (in rehabilitation), is a guarantor of public finance and structured finance obligations. ambac is also exploring opportunities involving the development or acquisition of new financial services businesses. ambac’s common stock trades on the nasdaq global select market (nasdaq: ambc)

AMBAC executives and stock owners

AMBAC executives and other stock owners filed with the SEC include:

• Claude LeBlanc,
  President, Chief Executive Officer, Director
• Claude L. LeBlanc,
  Pres, CEO & Director
• David Trick,
  Chief Financial Officer, Executive Vice President, Treasurer
• Stephen Ksenak,
  General Counsel, Senior Managing Director
• David Barranco,
  Senior Managing Director
• David Trick,
  Exec. VP, CFO & Treasurer
• R. Sharon Smith,
  Senior Managing Director, Chief of Staff
• Stephen Michael Ksenak,
  Sr. MD & Gen. Counsel
• David Peter Barranco,
  Sr. MD and Head of Risk Management & Corp. Devel.
• Rhonta Sharon Smith,
  Sr. MD & Chief of Staff
• Robert Eisman,
  Chief Accounting Officer, Senior Managing Director, Controller
• Jeffrey Stein,
  Independent Chairman of the Board
• David Herzog,
  Independent Director
• Alexander Greene,
  Independent Director
• Ian Haft,
  Independent Director
• Claude Prieur,
  Independent Director
• Joan Lamm-Tennant,
  Independent Director
• Lisa Kampf,
  Managing Director
• Michael Reilly,
  Chief Administrative Officer, Chief Information Officer, Senior Managing Director
• Kate Smith,
  Director of Corp. Communications
• Charles Joseph Sebaski,
  MD & Head of Investor Relation
• Daniel Matthew McGinnis,
  Sr. MD & COO
• Dan McGinnis,
  Sr. MD & COO
• Patrick McCormick,
  Managing Director
• Robert Bryan Eisman,
  Sr. MD, Chief Accounting Officer & Controller
• Robert G. Donovan,
  Chief Investment Officer
• Tavakoli Nader,
  Director
• C James Prieur,
  Director
• Cathleen Matanle,
  Senior Managing Director
• Eugene M Bullis,
  Director
• Victor E Mandel,
  Director
• Diana Adams,
  Chief Executive Officer
• Lisa G Iglesias,
  Director
• Michael D Price,
  Director
• Kristi Ann Matus,
  Director
• Daniel Mc Ginnis,
  Sr. MD & COO